United States News Todas as matérias

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical collaboration agreement with Swiss healthcare giant Roche to evaluate a novel combination therapy aimed at a genetically distinct and difficult-to-treat form of pancreatic cancer.

Apple (NASDAQ:AAPL) has agreed to supply local financial data to India's antitrust regulator, dropping its long-standing refusal to do so as part of a high-stakes probe into its mobile app marketplace dominance.

Victoria’s Secret shares jumped about 50% in a single session - the best day in the company’s history - after earnings showed sales up 15%, profit nearly quadrupled and earnings per share roughly double Wall Street expectations.

Zhihu (NYSE:ZH) reported a sharp increase in adjusted profitability for the first quarter of 2026, overcoming a contraction in top-line revenue through disciplined operational efficiency and reduced overhead.

DBV Technologies (NASDAQ:DBVT) has screened the first participant in its THRIVE study, evaluating the Viaskin Peanut patch in infants aged 6 to 12 months over a multi-year period.

Zenas BioPharma (NASDAQ:ZBIO) reported positive late-stage clinical trial results for its experimental autoimmune therapy, hitting its primary and all key secondary targets in a study that could position the treatment as a new standard of care for a rare, debilitating inflammatory condition.

Figure Technology Solutions (NASDAQ:FIGR) released preliminary operating data for May 2026 on Wednesday, demonstrating significant year-over-year acceleration across its blockchain-native capital marketplace.

Johnson & Johnson (NYSE:JNJ) disclosed new data on Wednesday showing its experimental autoimmune treatment, nipocalimab, yields stronger clinical results in patients with higher concentrations of specific disease-driving biomarkers.

Johnson & Johnson’s (NYSE:JNJ) experimental therapy for systemic lupus erythematosus successfully met its primary objective in a mid-stage clinical trial.

argenx (NASDAQ:ARGX) reported new clinical data for its neonatal Fc receptor (FcRn) blocker, Vyvgart (efgartigimod), demonstrating durable therapeutic benefits and a highly consistent safety profile for patients living with myositis and Sjogren’s disease.

BW LPG (NYSE:BWLP) announced that it has completed the sale of its entire 8.50% equity stake in Confidence Petroleum India, marking the shipping firm's full exit as a shareholder in the Indian downstream LPG provider.

The Sherwin-Williams Company (NYSE:SHW) and Tokyo-based Nippon Paint Group have officially terminated their joint efforts to acquire AkzoNobel, bringing an end to a high-profile pursuit that threatened to reshape the global paints and coatings industry.

BP (NYSE:BP) is weighing a total departure from the UK North Sea after more than 60 years of operation, following an aggressive series of tax hikes by the Labour government that have drastically shifted the economic viability of mature oil and gas basins.

Meta Platforms (NASDAQ:META) scored a partial victory in its legal battle against sweeping European Union digital regulations on Wednesday, as Europe's second-highest court overturned an antitrust label applied to its Marketplace platform while upholding the same restrictions for its Messenger app.

Karyopharm Therapeutics (NASDAQ:KPTI) announced that its late-breaking Phase 3 SENTRY clinical trial data has been selected for an oral presentation at the European Hematology Association (EHA) 2026 Congress, placing the treatment among the top six late-breaking abstracts at the event.

Quantum Corp. (NASDAQ:QMCO) announced select preliminary, unaudited financial results for its fiscal fourth quarter of 2026, highlighted by total revenue that is expected to come in significantly ahead of the company's previously issued guidance range.

INVO Fertility (NASDAQ:IVF) reported a 5% increase in total net revenue for fiscal year 2025, supported by steady expansion across its clinic network and a restructured balance sheet that eliminated several complex legacy equity liabilities.

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Vanderbilt Health announced that a Phase 2a clinical trial evaluating the investigational drug ifetroban successfully met its primary endpoint, demonstrating safety and tolerability in patients with high-risk solid tumors.

Castor Maritime (NASDAQ:CTRM) reported a significant turnaround in its financial performance for the first quarter of 2026, driven by steady operational growth and substantial non-operating gains from its investment holdings.

Legend Biotech (NASDAQ:LEGN) announced encouraging initial clinical data from an ongoing Phase 1 study evaluating LB2501, its experimental in vivo CD19/CD20 dual-targeting CAR-T therapy, for the treatment of patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

The Buckle (NYSE:BKE) announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per share, sustaining the retail company's program of regular distributions to its public investors.

Voyager Technologies (NYSE:VOYG) has signed a definitive agreement to acquire Astrobotic Technology, a privately held developer of commercial lunar delivery systems, surface power infrastructure, and reusable rockets.

Vera Therapeutics (NASDAQ:VERA) has reached an agreement with the U.S. Food and Drug Administration to accelerate the regulatory timeline for its experimental kidney disease treatment, clearing the path for an earlier analysis of pivotal Phase 3 data.

BeyondSpring (NASDAQ:BYSI) announced updated data from an investigator-initiated Phase 2 clinical trial evaluating a triple-combination therapy for patients with advanced lung cancer, demonstrating sustained overall survival and disease control in a difficult-to-treat population.